Treatment of neuromyelitis optica with rituximab: a 2-year prospective multicenter study
Authors:
- Philippe CabrePCPhilippe Cabre
- M. MejdoubiMMM. Mejdoubi
- On Behalf Of Francophone Society Of Multiple SclerosisOSOn Behalf Of Francophone Society Of Multiple Sclerosis
- OFSEP investigatorsOIOFSEP investigators
- 17 February 2018
- journal article
- research article
- Published by Springer Nature in Journal of Neurology
- Vol. 265 (4) , 917-925
Abstract
Neuromyelitis optica (NMO) is a very severe autoimmune disorder of the central nervous system. It affects young subjects and has a poor prognosis both on a functional and vital level. Therefore, it is imperative to reduce the frequency of relapses. The purpose of this study was to evaluate the clinical and neuroradiological effectiveness of rituximab (RTX) on active forms of NMO.Keywords
Funding Information
- Agence Nationale de la Recherche (ANR-10-COHO-002 Observatoire Français de la Sclérose en Plaques (OFSEP), by the Eugene Devic Foundation against Multiple Sclerosis (EDMUS Foundation))
This publication has 29 references indexed in Scilit:
- Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximabNeurology, 2011
- Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in miceBrain, 2010
- Neuromyelitis optica: Passive transfer to rats by human immunoglobulinBiochemical and Biophysical Research Communications, 2009
- Intrathecal pathogenic anti–aquaporin‐4 antibodies in early neuromyelitis opticaAnnals of Neurology, 2009
- Neuromyelitis optica immunoglobulins as a marker of disease activity and response to therapy in patients with neuromyelitis opticaMultiple Sclerosis Journal, 2008
- Antibody to aquaporin-4 in the long-term course of neuromyelitis opticaBrain, 2008
- NMO-IgG predicts the outcome of recurrent optic neuritisNeurology, 2008
- B cells move to centre stage: novel opportunities for autoimmune disease treatmentNature Reviews Drug Discovery, 2006
- Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitisAnnals of Neurology, 2006
- Long‐Lived Plasma Cells and Their Contribution to AutoimmunityAnnals of the New York Academy of Sciences, 2005